Gene: NDUFA3
Official Full Name: NADH:ubiquinone oxidoreductase subunit A3provided by HGNC
Gene Summary: Predicted to enable NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial respiratory chain complex I assembly. Located in mitochondrion. Part of mitochondrial inner membrane and respiratory chain complex I. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36449 | NDUFA3 Knockout cell line (HeLa) | Human | NDUFA3 | 1:3~1:6 | Negative | Online Inquiry |
KO36450 | NDUFA3 Knockout cell line (HCT 116) | Human | NDUFA3 | 1:2~1:4 | Negative | Online Inquiry |
KO36451 | NDUFA3 Knockout cell line (HEK293) | Human | NDUFA3 | 1:3~1:6 | Negative | Online Inquiry |
KO36452 | NDUFA3 Knockout cell line (A549) | Human | NDUFA3 | 1:3~1:4 | Negative | Online Inquiry |
NDUFA3 Gene Knockout Cell Lines represent a significant advancement in cellular biology by providing a model system specifically designed to study the implications of the NDUFA3 gene, which encodes a critical component of the mitochondrial respiratory chain complex I. These knockout cell lines are engineered through targeted genome editing techniques, such as CRISPR-Cas9, to effectively disable the function of the NDUFA3 gene, allowing researchers to investigate the resultant physiological and biochemical changes.
The primary function of these cell lines is to elucidate the role of NDUFA3 in cellular metabolism, energy production, and mitochondrial dysfunction. By observing the consequences of gene knockout, researchers can dissect the metabolic pathways influenced by NDUFA3 and its involvement in various diseases, including metabolic syndromes and neurodegenerative disorders. Furthermore, these models are crucial for understanding how alterations in mitochondrial function can impact overall cell health and contribute to the pathogenesis of mitochondrial diseases.
The scientific importance of NDUFA3 Gene Knockout Cell Lines extends into both basic research and clinical applications, particularly in drug discovery and translational medicine. These models facilitate the identification of potential therapeutic targets and the screening of compounds that can mitigate the effects of mitochondrial dysfunction, making them invaluable in the quest for new treatments.
Compared to traditional cell lines that maintain normal NDUFA3 expression, these knockout cell lines offer a unique advantage by providing a clear and specific genetic backdrop against which to analyze the consequences of NDUFA3 deficiency. This specificity aids in producing more reliable and interpretable experimental results, significantly enhancing the predictiveness of experimental outcomes.
For researchers and clinicians aiming to push the boundaries of mitochondrial research, the NDUFA3 Gene Knockout Cell Lines serve as an essential tool in their arsenal, enabling a deeper understanding of mitochondrial biology and fostering innovation in therapeutic strategies. Our company prides itself on its commitment to producing high-quality, accessible biological products, underpinned by our expertise in gene editing technologies and ongoing dedication to supporting the scientific community in its pursuit of excellence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.